BR102013019136A8 - processo one pot de síntese de nanocápsulas poliméricas, suas formas secas, composições farmacêuticas de nanocápsulas poliméricas e seus usos - Google Patents
processo one pot de síntese de nanocápsulas poliméricas, suas formas secas, composições farmacêuticas de nanocápsulas poliméricas e seus usosInfo
- Publication number
- BR102013019136A8 BR102013019136A8 BR102013019136A BR102013019136A BR102013019136A8 BR 102013019136 A8 BR102013019136 A8 BR 102013019136A8 BR 102013019136 A BR102013019136 A BR 102013019136A BR 102013019136 A BR102013019136 A BR 102013019136A BR 102013019136 A8 BR102013019136 A8 BR 102013019136A8
- Authority
- BR
- Brazil
- Prior art keywords
- polymeric nanocapsules
- polymeric
- pharmaceutical compositions
- nanocapsules
- synthesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102013019136A BR102013019136A8 (pt) | 2013-07-26 | 2013-07-26 | processo one pot de síntese de nanocápsulas poliméricas, suas formas secas, composições farmacêuticas de nanocápsulas poliméricas e seus usos |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102013019136A BR102013019136A8 (pt) | 2013-07-26 | 2013-07-26 | processo one pot de síntese de nanocápsulas poliméricas, suas formas secas, composições farmacêuticas de nanocápsulas poliméricas e seus usos |
Publications (2)
Publication Number | Publication Date |
---|---|
BR102013019136A2 BR102013019136A2 (pt) | 2015-11-10 |
BR102013019136A8 true BR102013019136A8 (pt) | 2021-02-23 |
Family
ID=54548394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102013019136A BR102013019136A8 (pt) | 2013-07-26 | 2013-07-26 | processo one pot de síntese de nanocápsulas poliméricas, suas formas secas, composições farmacêuticas de nanocápsulas poliméricas e seus usos |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR102013019136A8 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3735223A4 (en) * | 2018-01-05 | 2021-10-13 | Impel Neuropharma Inc. | INTRANASAL ADMINISTRATION OF OLANZAPINE BY A PRECISION OLFACTORY DEVICE |
-
2013
- 2013-07-26 BR BR102013019136A patent/BR102013019136A8/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR102013019136A2 (pt) | 2015-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020002269A1 (es) | Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433) | |
CL2019001553A1 (es) | Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador. | |
CL2016001629A1 (es) | Compuestos tricíclicos como agentes anticancerígenos | |
CL2016002310A1 (es) | Nuevos compuestos bicíclicos. | |
CL2018000596A1 (es) | Nuevos compuestos bicíclicos como inhibidores de la atx | |
BR112017007301A2 (pt) | estruturas fibrosas solúveis e métodos para a fabricação das mesmas | |
CL2014003444A1 (es) | Compuestos derivados tienopirimidina; proceso de preparacion; composicion farmaceutica que los comprende; combinacion farmaceutica; uso en el tratamiento de canceres y enfermedades autoinmunes. | |
CL2015002860A1 (es) | Antagonistas de la alfa-v-beta-6 integrina | |
CL2015000502A1 (es) | Nanoparticula polimerica de finasterida, suspension acuosa conteniendo a la misma, composicion para tratamiento de alopecia, proceso de preparacion de dicha composicion, y su uso. | |
CL2014001752A1 (es) | Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras. | |
UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
MA37206B1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CL2019002190A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984) | |
UY35661A (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que lo s contienen | |
CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
EA201792487A1 (ru) | Композиции гидроксипропил-бета-циклодекстринов и способы | |
CL2015002692A1 (es) | Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos. | |
CR20150367A (es) | Compuestos químicos | |
DOP2015000303A (es) | Letermovir amorfo y formulaciones farmacéuticas sólidas del mismo para administración por vía oral | |
DOP2012000250A (es) | COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SÍNTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO | |
EA201591618A1 (ru) | Замещенные имидазопиридазины | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
UY35905A (es) | Inhibidores del transporte de glucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: COMPLEMENTAR A RETRIBUICAO DA 3A ANUIDADE DE ACORDO COM TABELA VIGENTE , REFERENTE A GUIA DE RE COLHIMENTO 221508050010. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06V | Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/51 , A61K 9/20 , A61K 31/5513 , A61K 47/40 , A61K 47/30 , A61P 25/18 Ipc: A61K 9/51 (2006.01), A61K 31/551 (2006.01), A61K 9 |
|
B03H | Publication of an application: rectification [chapter 3.8 patent gazette] |
Free format text: REFERENTE A RPI 2340 DE10/11/2015, QUANTO AO ITEM (71). |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |